Chronic obstructive pulmonary disease (COPD) Trials in London, United Kingdom
Conditions / Chronic obstructive pulmonary disease (COPD) / London, United Kingdom
Chronic obstructive pulmonary disease (COPD) is a medical condition with active clinical research programs worldwide.
27 total trials for this combination
Showing top 10 of 27 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05595642 | A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease | RECRUITING | PHASE3 |
| NCT01202188 | A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |
| NCT06040086 | Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02059434 | Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPD | COMPLETED | PHASE1 |
| NCT04039113 | Tezepelumab COPD Exacerbation Study | COMPLETED | PHASE2 |
| NCT04631016 | A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis | COMPLETED | PHASE2 |
| NCT00363896 | A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |
| NCT07082738 | A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease | RECRUITING | PHASE2 |
| NCT01782326 | QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations) | COMPLETED | PHASE3 |
| NCT01462942 | Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination | COMPLETED | PHASE3 |